Manassas, Virginia — According to state and local development sources, Granules Consumer Health plans to invest $1,500,000.00 to build out new space in Manassas. The company plans to occupy the new space at 7413 Cushing Rd in Manassas, on or about May 1, 2025. According to the company website Granules India Ltd. is a fully integrated pharmaceutical manufacturer. The Company manufactures Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages (FDs) which are distributed in over 55 countries. Granules Consumer Health is Granules’ front-end products division for private label over the counter (OTC) products in the US products. GCH was established in 2014, to offer OTC generics that meet the highest level of quality at an affordable cost that is much more affordable than brand name products. Granules is well established on bulk supply through efficiencies garnered through manufacturing, integration, and a high level of regulatory compliance. GCH builds on the efficiencies on Granules India’s manufacturing, packages product in the US and supplies products to our store brand partners.

To learn more about Granules Consumer Health, visit http://granulesconsumerhealth.com/

Company Contact:
Nivaran Kapur, President
https://www.linkedin.com/in/nivarankapur/
973-770-3181

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.